Xenon Pharmaceuticals Inc (XENE)
Xenon Reports Second Quarter 2025 Financial Results & Business Update
Olema Oncology (OLMA)
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results
Standard Biotools Inc (LAB)
Standard BioTools Reports Second Quarter 2025 Financial Results
EVOGENE (EVGN)
Alpha Tau Medical Ltd (DRTS)
Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
FibroGen Inc (FGEN)
FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update
Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress
Catalyst Biosciences Inc. (CBIO)
New Form 8-K - GYRE THERAPEUTICS, INC. Filed: 2025-08-11 AccNo: 0000950170-25-106525 Size: 681 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial …
Xylo Technologies Ltd (XYLO)
Mind Medicine (MNMD)
MindMed Announces New Employee Inducement Grants
Veru Inc. (VERU)
Laxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru’s Enobosarm, Utilizing Laxxon’s SPID®-Technology
Arcturus Therapeutics Holdings Inc (ARCT)
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
Gyre Therapeutics Inc (GYRE)
Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update
Xenon Pharmaceuticals Inc (XENE)
Xenon Reports Second Quarter 2025 Financial Results & Business Update
Aquestive Therapeutics Inc (AQST)
Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update